EDGE
  • home.svg
    Home
  • news.svg
    All updates
  • news.svg
    EDGE Insights
  • list.svg
    Industries
  • db-search.svg
    Company Search
  • company-list.svg
    My Watchlists (Beta)
All Updates

All Updates

icon
Filter
Funding
Cultivated Biosciences raises USD 5 million in seed funding to develop and commercialize yeast-based creamer
Plant-based Dairy & Egg
Mar 6, 2024
This week:
Funding
EKORE raises EUR 1.3 million (~ USD 1 million) in seed funding to strengthen platform
Digital Twin
Yesterday
Funding
Culina Health raises USD 7.9 million in Series A funding to expand offerings and expand team
Functional Nutrition
Dec 19, 2024
FDA approval
ViGeneron receives IND clearance for VG801 gene therapy
Cell & Gene Therapy
Dec 19, 2024
Product updates
Reflex Aerospace ships first commercial satellite SIGI
Next-gen Satellites
Dec 19, 2024
Partnerships
Vast partners with SpaceX for two private astronaut missions to ISS
Space Travel and Exploration Tech
Dec 19, 2024
Management news
Carbios appoints Philippe Pouletty as interim CEO amid plant delay
Waste Recovery & Management Tech
Dec 19, 2024
Funding
BlueQubit raises USD 10 million in seed funding to develop quantum platform
Quantum Computing
Dec 19, 2024
FDA approval
Arbor Biotechnologies receives FDA clearance for ABO-101 IND application
Human Gene Editing
Dec 19, 2024
Partnerships
‧
Funding
Personalis partners with Merck and Moderna for cancer therapy development and investment
Precision Medicine
Dec 19, 2024
Partnerships
COTA partners with Guardant Health to develop clinicogenomic data solutions for cancer research
Precision Medicine
Dec 19, 2024
Plant-based Dairy & Egg

Plant-based Dairy & Egg

View industry hub
Mar 6, 2024

Cultivated Biosciences raises USD 5 million in seed funding to develop and commercialize yeast-based creamer

Funding

  • Swiss biotech food startup Cultivated Biosciences has raised USD 5 million in seed funding led by Navus Ventures, a Dutch venture capital firm.

  • The funds raised will primarily accelerate the startup's development of yeast cream. Additionally, the company plans to use a portion of the funds in preparation for its US market launch, slated for 2025.

  • The dairy-free cream is derived from yeast biomass fermentation and has been validated for food and beverage applications. The company plans to supply it to gastronomy and foodservice companies for use in final products.

  • Analyst QuickTake: This funding follows the firm's USD 1.5 million pre-seed round and the unveiling of its dairy-free creamer prototype. The company uses yeast biomass fermentation, which harnesses the high-protein content and rapid growth of microorganisms to develop protein-rich foods. This method differs from the commonly used precision fermentation that tries to replicate proteins on a molecular level.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.